The Food and Drug Administration is launching a pilot program intended to speed up the process of bringing new drug ...

Curing disease is one of AI's most tantalizing use cases, fetching billions of VC dollars, but thus far it's generated more ...

With oral cyclic peptides offering small molecule convenience and antibody‑like selectivity, the modality is gaining momentum ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

Identifying and accelerating drug development is big business. The costs in this industry are significant and finding pathways to optimize using AI methods is top of mind in this fast and evolving ...

A new two-step method makes more uniform antibody-drug conjugates by attaching cancer drugs at a precise antibody site, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...

AI, high-throughput screening, genomics and precision medicine are accelerating drug discovery, while rising disease burdens, R&D investment and emerging-market adoption create opportunities.Dublin, ...

Some drugs may seem like they were named by throwing darts at the alphabet – but the process of drug naming is actually very intentional. In an interview with Fox News Digital, Dr. Dave Latshaw, CEO ...